Picture of Laboratorios Farmaceuticos Rovi logo

ROVI — Laboratorios Farmaceuticos Rovi News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Rovi To Propose Capital Reduction Up To 3.3 Mln Treasury Shares

May 21 (Reuters) - Laboratorios Farmaceuticos ROVI SA
 ROVI.MC :
    * TO PROPOSE CAPITAL REDUCTION UP TO 3.3 MILLION TREASURY
SHARES
    * EACH SHARE HAS PAR VALUE OF 0.06 EUROS, REPRESENTING, AT
MOST,
6.20% OF THE COMPANY'S SHARE CAPITAL
    * MAXIMUM AMOUNT OF CAPITAL REDUCTION 200,857.14 EUROS

Source text for Eikon:  ID:nCNM8d3vm7 
Further company coverage:  ROVI.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Laboratorios Farmaceuticos Rovi

See all news